ArticleProceedings of the National Academy of Sciences of the United States of America2025

Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy with glyco-optimization and immune checkpoint blockade.

Po-Kai Chuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.